Ossibutinina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ossibutinina" in Italian language version.

refsWebsite

Global rank Italian rank

13nih.gov

4^th place

9^th place

4oadoi.org

799^th place

22^nd place

4doi.org

2^nd place

7^th place

doi.org

dx.doi.org

N. Wolosker, JR. de Campos; P. Kauffman; P. Puech-Leão, A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis., in J Vasc Surg, vol. 55, n. 6, Jun 2012, pp. 1696-700, DOI:10.1016/j.jvs.2011.12.039, PMID 22341836.
GW. Davila, Transdermal oxybutynin: a new treatment for overactive bladder., in Expert Opin Pharmacother, vol. 4, n. 12, Dec 2003, pp. 2315-24, DOI:10.1517/14656566.4.12.2315, PMID 14640930.
A. Sahai, R. Mallina; C. Dowson; T. Larner; MS. Khan, Evolution of transdermal oxybutynin in the treatment of overactive bladder., in Int J Clin Pract, vol. 62, n. 1, Jan 2008, pp. 167-70, DOI:10.1111/j.1742-1241.2007.01623.x, PMID 18173821.
DR. Staskin, S. Salvatore, Oxybutynin topical and transdermal formulations: an update., in Drugs Today (Barc), vol. 46, n. 6, Jun 2010, pp. 417-25, DOI:10.1358/dot.2010.46.6.1487750, PMID 20571610.

nih.gov

ncbi.nlm.nih.gov

AC. Diokno, J. Lapides, Oxybutynin: a new drug with analgesic and anticholinergic properties., in J Urol, vol. 108, n. 2, Aug 1972, pp. 307-9, PMID 5047425.
IM. Thompson, R. Lauvetz, Oxybutynin in bladder spasm, neurogenic bladder, and enuresis., in Urology, vol. 8, n. 5, Nov 1976, pp. 452-4, PMID 790746.
HG. Rushton, Older pharmacologic therapy for nocturnal enuresis., in Clin Pediatr (Phila), Spec No, Jul 1993, pp. 10-3, PMID 8039332.
AM. Marconi, E. Felici; A. Roggia; F. Torelli, [Anticholinergic treatment in the therapy of primary enuresis. Effectiveness of oxybutynin chloride in a controlled clinical study of 58 patients]., in Pediatr Med Chir, vol. 7, n. 4, Lug-Ago 1985, pp. 573-6, PMID 3915547.
GS. Mijnhout, H. Kloosterman; S. Simsek; RJ. Strack van Schijndel; JC. Netelenbos, Oxybutynin: dry days for patients with hyperhidrosis., in Neth J Med, vol. 64, n. 9, Oct 2006, pp. 326-8, PMID 17057269.
N. Wolosker, JR. de Campos; P. Kauffman; P. Puech-Leão, A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis., in J Vasc Surg, vol. 55, n. 6, Jun 2012, pp. 1696-700, DOI:10.1016/j.jvs.2011.12.039, PMID 22341836.
AB. Reitz, SK. Gupta; Y. Huang; MH. Parker; RR. Ryan, The preparation and human muscarinic receptor profiling of oxybutynin and N-desethyloxybutynin enantiomers., in Med Chem, vol. 3, n. 6, Nov 2007, pp. 543-5, PMID 18045203.
RH. Zobrist, B. Schmid; A. Feick; D. Quan; SW. Sanders, Pharmacokinetics of the R- and S-enantiomers of oxybutynin and N-desethyloxybutynin following oral and transdermal administration of the racemate in healthy volunteers., in Pharm Res, vol. 18, n. 7, Jul 2001, pp. 1029-34, PMID 11496941.
GW. Davila, Transdermal oxybutynin: a new treatment for overactive bladder., in Expert Opin Pharmacother, vol. 4, n. 12, Dec 2003, pp. 2315-24, DOI:10.1517/14656566.4.12.2315, PMID 14640930.
A. Sahai, R. Mallina; C. Dowson; T. Larner; MS. Khan, Evolution of transdermal oxybutynin in the treatment of overactive bladder., in Int J Clin Pract, vol. 62, n. 1, Jan 2008, pp. 167-70, DOI:10.1111/j.1742-1241.2007.01623.x, PMID 18173821.
DR. Staskin, S. Salvatore, Oxybutynin topical and transdermal formulations: an update., in Drugs Today (Barc), vol. 46, n. 6, Jun 2010, pp. 417-25, DOI:10.1358/dot.2010.46.6.1487750, PMID 20571610.
Kachur JF, et al. R and S enantiomers of oxybutynin: pharmacological effects in guinea pig bladder and intestine, Journal of Pharmacology and Experimental Therapeutics, 247, S. 867–872, 1988; PMID 2849672.
Noronha-Blob L, Kachur JF. Enantiomers of oxybutynin: in vitro pharmacological characterization at M₁, M₂ and M₃ muscarinic receptors and in vivo effects on urinary bladder contraction, mydriasis and salivary secretion in guinea pigs, Journal of Pharmacology and Experimental Therapeutics, 256, S. 562–567, 1991; PMID 1993995.

oadoi.org

N. Wolosker, JR. de Campos; P. Kauffman; P. Puech-Leão, A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis., in J Vasc Surg, vol. 55, n. 6, Jun 2012, pp. 1696-700, DOI:10.1016/j.jvs.2011.12.039, PMID 22341836.
GW. Davila, Transdermal oxybutynin: a new treatment for overactive bladder., in Expert Opin Pharmacother, vol. 4, n. 12, Dec 2003, pp. 2315-24, DOI:10.1517/14656566.4.12.2315, PMID 14640930.
A. Sahai, R. Mallina; C. Dowson; T. Larner; MS. Khan, Evolution of transdermal oxybutynin in the treatment of overactive bladder., in Int J Clin Pract, vol. 62, n. 1, Jan 2008, pp. 167-70, DOI:10.1111/j.1742-1241.2007.01623.x, PMID 18173821.
DR. Staskin, S. Salvatore, Oxybutynin topical and transdermal formulations: an update., in Drugs Today (Barc), vol. 46, n. 6, Jun 2010, pp. 417-25, DOI:10.1358/dot.2010.46.6.1487750, PMID 20571610.